T1	Outcomes 4 23	efficacy and safety
T2	Outcomes 199 218	safety and efficacy
T3	Outcomes 647 747	rate of biopsy-confirmed acute rejection (BCAR) and renal function, as measured by serum creatinine.
T4	Outcomes 824 828	BCAR
T5	Outcomes 935 956	Mean serum creatinine
T6	Outcomes 1039 1063	and creatinine clearance
T7	Outcomes 1215 1228	respectively.
T8	Outcomes 1229 1255	Patient and graft survival
T9	Outcomes 1300 1338	differences in infection or malignancy
T10	Outcomes 1429 1528	excellent 12-month patient and graft survival, a low incidence of BCAR, and improved renal function
T11	Outcomes 1622 1648	adequate immunosuppression
T12	Outcomes 1678 1721	for the nephrotoxic effects of cyclosporine
